Cure First

06/04/2026

BIG NEWS!! $100K Donor Match for THE KIDS in June! Help us raise $200K to help kids get Cure FIrst's PARIS test!

Cure First is collaborating with Cancer Revengers, the maverick's of pediatric brain cancers who are changing everything. Several generous donors have come together to match up to $100K in June, a total of up to $200K if we max it out! The cancer kids are the little soldiers often left behind and we're teaming up with Cancer Revengers to begin to fix that. Please donate today and honor the late Cancer Revenger co-founder and original superhero, Layla, who absolutely changed the game in functional precision medicine for kids. We are thrilled to be a part of this movement for kids and thank you for all of your support. Let's hit $200K in June so please share this and send to friends!

Donate at cure-first.org/kids

04/30/2026

Following an inspiring week at AACR 2026, Cure First is doubling down on our mission to redefine precision oncology. We are currently refining our functional drug screening data to provide oncologists with a clearer, more actionable roadmap for selecting the next line of treatment—ensuring every patient gets the right therapy at the right time.

03/23/2026

We are excited to announce that Dr. Carla Grandori will be speaking at in Seattle at the Stuart & Molly Sloan Precision Oncology Institute Symposium on Functional Precision Oncology on March 26, 2026.

Dr. Grandori will discuss clinical outcomes and exceptional patient responses observed with the PARIS Test.

We hope to see you there, you may register for the event using the following link:

https://www.fredhutch.org/en/events/stuart-and-molly-sloan-precision-oncology-institute-functional-p.html

We look forward to an engaging discussion on the future of functional precision oncology.

PARIS Test Team

Save the Date: the Sloan Precision Oncology Institute is hosting a Symposium on Functional Precision Oncology on March 26, 2026. This symposium will feature a panel of local and national leaders in the field who will deliver talks and join in discussions on the latest advances in Functional Precisio...

03/04/2026

Dear Colleagues, Friends, and Family,
The PARIS test laboratory has officially reopened. Our team is back together.
In our very first week, we received seven new patient requests, reminding us that the need is real and urgent.

This is not about funding a laboratory for its own sake.
It is about empowering patients and their oncologists to avoid trial and error when time is short and options are limited.
If you believe treatment decisions should be informed by real biological data — especially when cancer has recurred — we invite you to consider supporting this effort, and if you already donated simply consider sharing the campaign.
Every contribution helps. Sharing helps. Momentum matter
With deep appreciation,
Carla
and the PARIS Team
Test the drugs. Not the patient.

03/02/2026

Dear Colleagues, Friends, and Family,

The PARIS test laboratory has officially reopened. Our team is back together.

In our very first week, we received seven new patient requests, reminding us that the need is real and urgent.

Because of you, we raised $203,100 and secured an additional $50,000 reserve, making reopening possible. We are profoundly grateful. Yet reopening was only the first milestone. To remain available to patients, the laboratory now needs sustained support.

This is not about funding a laboratory for its own sake.

It is about empowering patients and their oncologists to avoid trial and error when time is short and options are limited.

If you believe treatment decisions should be informed by real biological data — especially when cancer has recurred — we invite you to consider supporting this effort, and if you already donated simply consider sharing the campaign.

Every contribution helps. Sharing helps. Momentum matters.

Please visit our campaign here:

https://www.gofundme.com/f/how-do-you-know-a-cancer-treatment-will-work

With deep appreciation,

Carla
and the PARIS Team

Test the drugs. Not the patient.

Empowering Cancer Patients With Data-Driven Treatment Decisions When can… Carla Grandori needs your support for How Do You Know a Cancer Treatment Will Work?

04/07/2023

Dear Cure First Friends and Supporters,

As you are aware we have been fundraising to help Szymon Sawicki obtain crucial personalized vaccines to fight his stage 3 Pancreatic Adenocarcinoma. This cause is very important for Szymon and his family because these novel approaches are not yet reimbursed by insurance.

Your support to date has been crucial to cover a portion of the expenses associated with the vaccine, which costs $80,000. Cure First has contributed an initial deposit of $20,000 from its existing funds and, with your contributions, together we have raised an additional $5,321.

Szymon still needs your help in reaching his fundraising goal of an additional $54,679.

Would you be willing to make a contribution to Szymon’s campaign? A gift of any amount would get Szymon closer to receiving life-saving treatment . The vaccine will be ready at the end of April and will be administered monthly. Syzmon’s oncologist is ready for Szymon to receive the first injection.

To donate, simply click the link to Szymon’s campaign below:

https://www.curefirst.org/specialcampaign-szymon-sawicki

Please share Szymon’s story and this fundraiser link with everyone you know. The more eyes on Szymon’s campaign, the better!


Thank you in advance for any and all contributions.

I was diagnosed with stage 3 Pancreatic Adenocarcinoma in September of 2021. My wife, Jeannie, has spent countless hours researching the best tools and therapies to keep this terrifying disease at bay. For anyone who doesn't know, the average survival time for a patient with stage 3 Pancreatic Cance...

12/15/2022

Thanks to all who have contributed to our campaign to help medical experts personalize a pancreatic cancer vaccine for Szymon Sawicki. You can read more about Szymon and donate here: https://www.curefirst.org/specialcampaign-szymon-sawicki. Help us continue to raise funds by choosing Cure First as your designated 501c3 nonprofit when you make purchases on Amazon. We are grateful for your support.

I was diagnosed with stage 3 Pancreatic Adenocarcinoma in September of 2021. My wife, Jeannie, has spent countless hours researching the best tools and therapies to keep this terrifying disease at bay. For anyone who doesn't know, the average survival time for a patient with stage 3 Pancreatic Cance...

12/03/2019

Thank you for your continued support of our commitment to find more effective and less toxic treatments for children with neuroblastoma. Your contributions today will allow us to continue our research and help us share our findings at the upcoming Advances in Neuroblastoma Research conference this May in Amsterdam.

curefirst.org/donate-2

11/16/2019

NATIONAL PHILANTHROPY DAY

Help us help others.

Your donations will advance our efforts to develop more effective and less toxic treatments for patients with neuroblastoma and ovarian cancer.

http://curefirst.org/donate-2

Thank you,
The Cure First Team

10/02/2019

Xander is why we do the work we do. He has high-risk neuroblastoma. Cure First is dedicated to finding safe and effective treatments for this childhood cancer.

"Xander started chemotherapy immediately to battle the cancer that had already spread throughout his body. He has a large tumor growing out of his upper back bone as well bone marrow disease and bone lesions in his legs, his pelvis, his spine and his skull.

His diagnosis requires long stints of intense treatment, which has been "difficult" for Xander, his mother and his 3-year-old-sister Olivia...And so far, treatment has not worked."

Xander Bowman lost his hearing during an intense type of chemotherapy.